Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: The Framingham Study

被引:92
作者
Osgood, D
Corella, D
Demissie, S
Cupples, LA
Wilson, PWF
Meigs, JB
Schaefer, EJ
Coltell, O
Ordovas, JM
机构
[1] Tufts Univ, Nutr & Genom Lab, Jean Mayer Human Nutr Res Ctr Aging, USDA, Boston, MA 02111 USA
[2] Tufts Univ, Lipid Metab Lab, Jean Mayer Human Nutr Res Ctr Aging, USDA, Boston, MA 02111 USA
[3] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Boston, MA 02118 USA
[5] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA
[6] Massachusetts Gen Hosp, Gen Internal Med Dept, Boston, MA 02114 USA
关键词
D O I
10.1210/jc.2002-021664
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The scavenger receptor class B type I ( SR- BI) is a key component in the reverse cholesterol transport pathway. We have previously reported three common polymorphisms associated with plasma lipids and body mass index. We hypothesized that diabetic status may interact with these polymorphisms in determining plasma lipid concentrations and particle size. We evaluated this hypothesis in 2463 nondiabetic ( 49% men) and 187 diabetic ( 64% men) participants in the Framingham Study. SR- BI and APOE genotypes, anthropometric, clinical, biochemical, and lifestyle variables were determined. After multivariate adjustment, we found a consistent association between the exon 8 polymorphism and high- density lipoprotein cholesterol concentration and particle size. Interaction effects were not significant for exon 8 and intron 5 polymorphisms. However, we found statistically significant interactions between SR- BI exon 1 genotypes and type 2 diabetes, indicating that diabetic subjects with the less common allele ( allele A) have lower lipid concentrations. For low- density lipoprotein cholesterol, the adjusted means ( +/- SE) were 3.31 +/- 0.03 and 3.29 +/- 0.04 mmol/ liter for G/ G and G/ A or A/ A in nondiabetics, respectively, compared with 3.19 +/- 0.10 and 2.75 +/- 0.01 mmol/ liter for G/ G and G/ A or A/ A in diabetics ( P = 0.03 for interaction). Similar results were obtained for HDL2- C. In conclusion, SR- BI gene variation modulates the lipid profile, particularly in type 2 diabetes, contributing to the metabolic abnormalities in these subjects.
引用
收藏
页码:2869 / 2879
页数:11
相关论文
共 57 条
[1]   Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [J].
Acton, S ;
Rigotti, A ;
Landschulz, KT ;
Xu, SZ ;
Hobbs, HH ;
Krieger, M .
SCIENCE, 1996, 271 (5248) :518-520
[2]   Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population [J].
Acton, S ;
Osgood, D ;
Donoghue, M ;
Corella, D ;
Pocovi, M ;
Cenarro, A ;
Mozas, P ;
Keilty, J ;
Squazzo, S ;
Woolf, EA ;
Ordovas, JM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (07) :1734-1743
[3]   Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene [J].
Arai, T ;
Wang, N ;
Bezouevski, M ;
Welch, C ;
Tall, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) :2366-2371
[4]   Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q [J].
Bektas, A ;
Suprenant, ME ;
Wogan, LT ;
Plengvidhya, N ;
Rich, SS ;
Warram, JH ;
Krolewski, AS ;
Doria, A .
DIABETES, 1999, 48 (11) :2246-2251
[5]   Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice [J].
Braun, A ;
Trigatti, BL ;
Post, MJ ;
Sato, K ;
Simons, M ;
Edelberg, JM ;
Rosenberg, RD ;
Schrenzel, M ;
Krieger, M .
CIRCULATION RESEARCH, 2002, 90 (03) :270-276
[6]   High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein [J].
Calabresi, L ;
Franceschini, G .
CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (04) :219-224
[7]   Structure and localization of the human gene encoding SR-BI/CLA-1 - Evidence for transcriptional control by steroidogenic factor 1 [J].
Cao, GP ;
Garcia, CK ;
Wyne, KL ;
Schultz, RA ;
Parker, KL ;
Hobbs, HH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) :33068-33076
[8]   Hepatic lipase: new insights from genetic and metabolic studies [J].
Cohen, JC ;
Vega, GL ;
Grundy, SM .
CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) :259-267
[9]  
CUPPLES LA, 1992, CIRCULATION, V85, P11
[10]  
de Beer FC, 2000, J LIPID RES, V41, P1849